Neural ID provides the only enterprise biosignal analytics platform

spanning the research and development lifecycle. The software

combines expert knowledge with machine learning to analyze raw signal data

from any source and to output actionable results to any reporting tool.




Neural ID software is used by leading life sciences companies to automate recognition and analysis of key biosignals, supporting a range of assays for safety assessment. Research scientists use the platform's expert-driven machine learning, massive data reduction and interoperable data format to increase productivity, reduce development costs and speed time to market.


5 of the top 10 pharmaceutical companies use Neural ID’s enterprise software platform to deliver cutting-edge biosignal analytics.


Neural ID works across the entire pharmaceutical lifecycle and can be leveraged in a variety of scenarios, including:


     •  Multi-Electrode Array Analysis

     •  Pre-Clinical Cardiac Safety

     •  Proarrhythmic Risk Prediction

     •  Label-Free Cell-Based Screening

     •  Ion Channel Data

     •  Real-Time PCR Analysis



News & Events

Feb 7-11



Feb 15-20



Mar 22-26



Apr 21-23



May 5-7



Jun 10-12



Jul 18-20


SLAS 2015

Washington DC


Molecular Med TRI-CON

San Francisco CA


Society of Toxicology

San Diego CA


BioIT World Conference

Boston MA


Biomarkers & Diagnostics World Philadelphia PA


World Preclinical Congress

Boston MA


Next Generation DX Summit Washington DC

"The combination of AI with these new drug discovery platforms will speed the delivery of new drug therapies and revolutionize Life Sciences productivity.”

— Neural Dude







© 2013 Neural ID

Neural ID

Providing enterprise-class waveform analytics
to the Health Sciences industry

Neural ID

Post Office Box 123

San Carlos, CA 94070